Effects  	Effects  	 NNS	O
of  	of  	 IN	O
Escitalopram  	Escitalopram  	 NNP	B-NP
on  	on  	 IN	O
a  	a  	 DT	O
Rat  	Rat  	 NNP	O
Model  	Model  	 NNP	O
of  	of  	 IN	O
Persistent  	Persistent  	 NNP	B-NP
Stress-Altered  	Stress-Altered  	 NNP	I-NP
Hedonic  	Hedonic  	 NNP	I-NP
Activities 	Activities 	 NNPS	I-NP
:  	:  	 :	O
Towards  	Towards  	 NNP	O
a  	a  	 DT	O
New  	New  	 NNP	B-NP
Understanding  	Understanding  	 NNP	I-NP
of  	of  	 IN	O
Stress  	Stress  	 NNP	O
and  	and  	 CC	O
Depression  	Depression  	 NNP	O
Chronic  	Chronic  	 NNP	B-NP
mild  	mild  	 JJ	I-NP
stress  	stress  	 NN	I-NP
( 	( 	 -LRB-	O
CMS 	CMS 	 NNP	B-NP
)  	)  	 -RRB-	O
paradigm  	paradigm  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
model  	model  	 NN	O
to  	to  	 TO	O
simulate  	simulate  	 VB	O
clinical  	clinical  	 JJ	B-NP
depression  	depression  	 NN	I-NP
induced  	induced  	 NN	I-NP
by  	by  	 IN	O
long-term  	long-term  	 JJ	O
environmental  	environmental  	 JJ	B-NP
stress 	stress 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
escitalopram 	escitalopram 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
specific  	specific  	 JJ	B-NP
serotonin  	serotonin  	 FW	I-NP
reuptake  	reuptake  	 FW	I-NP
inhibitor  	inhibitor  	 FW	I-NP
( 	( 	 -LRB-	O
SSRI 	SSRI 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
on  	on  	 IN	O
depression-like  	depression-like  	 JJ	B-NP
activities  	activities  	 NNS	I-NP
in  	in  	 IN	O
adult  	adult  	 NN	B-NP
( 	( 	 -LRB-	O
18  	18  	 CD	O
week-old 	week-old 	 NN	B-NP
)  	)  	 -RRB-	O
Sprague-Dawley  	Sprague-Dawley  	 NNP	B-NP
( 	( 	 -LRB-	O
SD 	SD 	 NNP	B-NP
)  	)  	 -RRB-	O
rats  	rats  	 NNS	O
that  	that  	 WDT	O
underwent  	underwent  	 VBD	O
a  	a  	 DT	O
total  	total  	 JJ	O
8-week  	8-week  	 NNP	O
CMS 	CMS 	 NNP	O
.  	.  	 .	O
Body  	Body  	 NN	O
weight 	weight 	 NN	O
,  	,  	 ,	O
locomotor  	locomotor  	 JJ	B-NP
activity  	activity  	 NN	I-NP
and  	and  	 CC	O
sucrose  	sucrose  	 JJ	B-NP
consumption  	consumption  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
rats  	rats  	 NNS	O
were  	were  	 VBD	O
measured  	measured  	 VBN	O
under  	under  	 IN	O
CMS  	CMS  	 NNP	B-NP
paradigm  	paradigm  	 NN	O
and  	and  	 CC	O
following  	following  	 VBG	O
escitalopram  	escitalopram  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
plasma  	plasma  	 JJ	B-NP
level  	level  	 NN	I-NP
of  	of  	 IN	I-NP
corticosterone  	corticosterone  	 NN	I-NP
was  	was  	 VBD	O
also  	also  	 RB	O
measured  	measured  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
experiment 	experiment 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
revealed  	revealed  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
CMS  	CMS  	 NNP	B-NP
program  	program  	 NN	O
reduced  	reduced  	 VBD	O
the  	the  	 DT	O
body  	body  	 NN	O
weight 	weight 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
the  	the  	 DT	O
locomotor  	locomotor  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
rats 	rats 	 NNS	O
.  	.  	 .	O
Adult  	Adult  	 NNP	B-NP
SD  	SD  	 NNP	I-NP
rats  	rats  	 NNS	I-NP
consumed  	consumed  	 VBN	O
less  	less  	 RBR	O
sucrose  	sucrose  	 JJ	B-NP
solution  	solution  	 NN	I-NP
under  	under  	 IN	O
CMS 	CMS 	 NNP	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
chronic  	chronic  	 JJ	B-NP
escitalopram  	escitalopram  	 JJ	I-NP
regime  	regime  	 NN	I-NP
( 	( 	 -LRB-	O
10  	10  	 CD	O
mg 	mg 	 CD	B-NP
/ 	/ 	 CD	I-NP
kg 	kg 	 CD	I-NP
/ 	/ 	 CD	I-NP
day  	day  	 NN	I-NP
for  	for  	 IN	O
4  	4  	 CD	O
weeks 	weeks 	 NNS	O
)  	)  	 -RRB-	O
appeared  	appeared  	 VBD	O
not  	not  	 RB	O
helpful  	helpful  	 JJ	O
in  	in  	 IN	O
reversing  	reversing  	 VBG	O
this  	this  	 DT	O
CMS  	CMS  	 NNP	B-NP
effect  	effect  	 NN	I-NP
and 	and 	 CC	O
,  	,  	 ,	O
if  	if  	 IN	O
any 	any 	 DT	O
,  	,  	 ,	O
the  	the  	 DT	O
drug  	drug  	 NN	O
exaggerated  	exaggerated  	 JJ	O
anxiety  	anxiety  	 NN	B-NP
profile  	profile  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
animals 	animals 	 NNS	O
.  	.  	 .	O
Unexpectedly 	Unexpectedly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
stressed  	stressed  	 JJ	O
rats  	rats  	 NNS	O
exhibited  	exhibited  	 VBP	O
higher  	higher  	 RBR	O
sucrose  	sucrose  	 JJ	B-NP
consumption  	consumption  	 NN	I-NP
than  	than  	 IN	O
non-stressed  	non-stressed  	 JJ	B-NP
rats  	rats  	 NNS	I-NP
after  	after  	 IN	O
receiving  	receiving  	 VBG	O
repeated  	repeated  	 VBN	O
saline  	saline  	 JJ	B-NP
injections 	injections 	 NNS	I-NP
.  	.  	 .	O
Further 	Further 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
stressed  	stressed  	 JJ	O
rats  	rats  	 NNS	O
were  	were  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
plasma  	plasma  	 JJ	B-NP
level  	level  	 NN	I-NP
of  	of  	 IN	I-NP
corticosterone  	corticosterone  	 NN	I-NP
after  	after  	 IN	O
escitalopram  	escitalopram  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
provide  	provide  	 VBP	O
an  	an  	 DT	O
example  	example  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
that  	that  	 WDT	O
previously  	previously  	 RB	O
stressed  	stressed  	 VBD	O
individuals  	individuals  	 NNS	O
may  	may  	 MD	O
develop  	develop  	 VB	O
an  	an  	 DT	O
anti-depression  	anti-depression  	 JJ	B-NP
ability  	ability  	 NN	I-NP
that  	that  	 IN	O
lessens  	lessens  	 VBG	O
the  	the  	 DT	O
benefits  	benefits  	 NNS	O
of  	of  	 IN	O
intervention  	intervention  	 NN	B-NP
with  	with  	 IN	O
antidepressants 	antidepressants 	 NN	B-NP
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
separate  	separate  	 JJ	O
group  	group  	 NN	O
of  	of  	 IN	O
rats  	rats  	 NNS	O
that  	that  	 WDT	O
entered  	entered  	 VBD	O
the  	the  	 DT	O
CMS  	CMS  	 NNP	B-NP
program  	program  	 NN	O
at  	at  	 IN	O
10  	10  	 CD	O
week-old  	week-old  	 NN	B-NP
were  	were  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
examine  	examine  	 VB	O
possible  	possible  	 JJ	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
aging  	aging  	 VBG	O
to  	to  	 TO	O
interpret  	interpret  	 VB	O
the  	the  	 DT	O
stress  	stress  	 NN	O
coping  	coping  	 VBG	B-NP
ability  	ability  	 NN	I-NP
observed  	observed  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
18  	18  	 CD	O
week-old  	week-old  	 JJ	B-NP
rats 	rats 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
younger  	younger  	 JJR	O
rats  	rats  	 NNS	O
developed  	developed  	 VBD	O
less  	less  	 RBR	O
anti-anhedonia  	anti-anhedonia  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
under  	under  	 IN	O
repeated  	repeated  	 VBN	O
saline  	saline  	 JJ	B-NP
injections 	injections 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
provide  	provide  	 VB	O
a  	a  	 DT	O
different  	different  	 JJ	O
perspective  	perspective  	 NN	O
on  	on  	 IN	O
stress-induced  	stress-induced  	 JJ	O
depression  	depression  	 NN	O
and  	and  	 CC	O
possible  	possible  	 JJ	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
antidepressants 	antidepressants 	 NN	B-NP
.  	.  	 .	O
